Excellence In Peptide And Oligonucleotide Purification: Advanced Process Solutions

By Niddhivinayak S Mishra, Yvan Ruland, Ph.D., Balaji S S, and Patil Vaibhav, Sartorius

Peptide and oligonucleotide therapies are reshaping the treatment landscape, with GLP-1 receptor agonists emerging as a key innovation in managing diabetes and obesity. As demand grows, so does the need for efficient downstream processing. This white paper highlights proven technologies designed specifically for peptide production, emphasizing how they can enhance purification workflows for GLP-1 receptor agonists. By integrating digital tools and data analytics, these solutions support real-time troubleshooting, streamline development, and accelerate scale-up. Case studies illustrate how these technologies can be configured to improve process efficiency and maintain a competitive edge in a fast-evolving market.

Whether you're optimizing existing workflows or scaling up production, access the full white paper to gain practical insights to help drive operational excellence.